Skip to content

Cart

Your cart is empty

Article: Online Sale of Over-the-Counter Medicines Approved in the EU

Aprovada a Venda Online de Medicamentos Sem Receita na UE

Online Sale of Over-the-Counter Medicines Approved in the EU

The Court of Justice of the European Union (CJUE) has authorized the online sale of non-prescription medicines, allowing platforms to act as intermediaries between pharmacies and customers. This decision marks a significant advancement in the regulation of pharmaceutical e-commerce in Europe, albeit with certain conditions to be met.

Key Points

  • The CJUE determines that only authorized pharmacies may sell non-prescription medicines.
  • Online platforms must act only as intermediaries, without conducting direct sales.
  • Member States cannot prohibit the intermediation of platforms that connect pharmacies and customers.

Context of the Decision

The CJUE's decision was prompted by a case brought by the Paris Court of Appeal, which questioned the legality of the Doctipharma platform. This platform allows for the purchase of non-prescription medicines directly from pharmacy websites. The Union of Community Pharmacists (UDGPO) challenged this practice, arguing that French legislation prohibits the participation of non-pharmacists in the e-commerce of medicines.

Requirements for Online Sales

The CJUE ruling establishes that:

  1. Authorized Pharmacies: Only duly licensed pharmacies may sell non-prescription medicines.
  2. Permitted Intermediation: Platforms may act as intermediaries, provided they do not conduct the direct sale of medicines.
  3. National Regulation: Each Member State is responsible for defining who can sell medicines online and ensuring that distance selling is conducted safely.

Implications for E-commerce

The CJUE's decision opens new opportunities for pharmaceutical e-commerce in Europe, allowing pharmacies to expand their reach through online platforms. However, pharmacies and platforms must be aware of local regulations and ensure they operate within established legal limits.

Conclusion

The approval of the online sale of non-prescription medicines by the CJUE represents an important step toward the modernization of the pharmaceutical sector in Europe. With appropriate regulation, this practice can improve access to medicines and facilitate purchasing for consumers, while simultaneously ensuring safety and compliance with public health laws.

Sources